Welcome to the new Gustave Roussy website

A new website designed to offer you a simpler, clearer, and more intuitive experience. Patients, caregivers, healthcare professionals, and donors: find information, news, and services more easily.

News

Prof. Alexander Eggermont awarded with "Docteur Honoris Causa"

Prof. Alexander Eggermont, general director of Gustave Roussy, received the "Docteur Honoris Causa" by The Medical Faculty of the University of Duisburg-Essen for his outstanding achievements.

Published on

Changed on

Prof. Alexander Eggermont, general director of Gustave Roussy, received the "Docteur Honoris Causa" by The Medical Faculty of the University of Duisburg-Essen for his outstanding achievements.

This prestigious award was given by Dean Prof. Jan Buer.

► More information on University of Duisburg-Essen website

Last news

  • Drug shortages: Gustave Roussy becomes the only Cancer Centre in France authorised to produce Special Hospital Preparations

    The Clinical Pharmacy Department at Gustave Roussy has been authorised by the French Ministry of Health to manufacture Special Hospital Preparations (SHPs). Granted for a period of seven years, this accreditation enables the Institute’s hospital pharmacy to produce certain medicines in coordination with the French National Agency for the Safety of Medicines and Health Products (ANSM) and the Ministry of Health. Gustave Roussy is the only French Comprehensive Cancer Centre (CLCC) authorised to manufacture Special Hospital Preparations, alongside ten university hospitals.

    Illustration Laboratoire
  • Personalising Breast Cancer Treatments: 5 Questions with Dr Barbara Pistilli

    Advances in treatment and patient care mean that five-year net survival for breast cancer now reaches 88%1 in France. However, with around 60,000 new cases diagnosed each year in France alone, breast cancer remains a major public health challenge. One reason is the side effects associated with treatment. In response to this issue, Dr Barbara Pistilli, Head of the Breast Cancer Committee at Gustave Roussy, advocates an approach centred on personalised care, ensuring that each woman receives a treatment intensity tailored to her tumour and individual journey, without compromising her chances of recovery.

    Dr Barbara Pistilli
  • Breast Cancer: Gustave Roussy Ranked No. 1 in France for Breast Surgery and Breast Reconstruction

    On the occasion of Breast Cancer Awareness Month, the 2025 data from Visuchir, the national surgical activity monitoring tool of the French Health Insurance system, places Gustave Roussy in first position for both breast surgery and breast reconstruction. Beyond this ranking, these figures highlight that reconstruction is now an integral part of breast cancer treatment. It is considered at every stage of care: from tumor removal surgery, whether lumpectomy or mastectomy, through to the post-cancer period, helping to restore the body and support women in regaining their physical integrity and quality of life.

    Photographie - chirurgiens en salle d'opération
  • Newsweek Ranking: Gustave Roussy Named Europe’s Leading Cancer Centre and Third Best Worldwide

    The 2027 edition of Newsweek’s World's Best Specialized Hospitals ranking once again recognises Gustave Roussy as the leading cancer centre in France and Europe, and the third best worldwide. This distinction highlights the excellence of the Institute’s care and research, as well as the daily commitment of all its professionals.

    Badge Word's best specialized hospitals